Copied to clipboard!
Longitudinal ctDNA profiling in in MGMT-silenced metastatic colorectal cancer ctDNA exome
This study elucidates how MGMT-silenced MSS colorectal cancers evolve under temozolomide and immunotherapy. ctDNA was isolated from serially collected plasma samples at baseline, post-TMZ induction, during immunotherapy and, when available, at disease progression. Changes in DNA sequence under these conditions were used to study which mutations may be driving tumour progression.
- Type: Exome Sequencing
- Archive: European Genome-phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD50000002574 | Illumina NovaSeq 6000 | 123 |
